Abstract
More than one million people in Italy have dementia and nearly 900 thousand people are affected by Mild cognitive impairment (MCI). No effective treatments are yet to be approved and acetylcholinesterase inhibitors (AChEi) and memantine are currently used to reduce cognitive decline related symptoms. Aim of the study is to provide a comprehensive analysis of anti-dementia drugs consumption in Italy between 2014 and 2020 with an analysis of demographic characteristics of the prevalent and incident users. The association between AChEI and memantine or anti-dementia and antipsychotic drugs will be also considered.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
